Colfax Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended October 01, 2021
November 04, 2021 at 10:14 am
Share
Colfax Corporation reported earnings results for the third quarter and nine months ended October 01, 2021. For the third quarter, the company reported sales was USD 965.89 million compared to USD 805.93 million a year ago. Net income was USD 25.85 million compared to USD 13.41 million a year ago. Basic earnings per share from continuing operations was USD 0.51 compared to USD 0.36 a year ago. Diluted earnings per share from continuing operations was USD 0.51 compared to USD 0.36 a year ago. Basic earnings per share was USD 0.48 compared to USD 0.3 a year ago. Diluted earnings per share was USD 0.48 compared to USD 0.3 a year ago.
For the nine months, sales was USD 2,831.03 million compared to USD 2,242.65 million a year ago. Net income was USD 73.56 million compared to USD 9.41 million a year ago. Basic earnings per share from continuing operations was USD 1.68 compared to USD 0.45 a year ago. Diluted earnings per share from continuing operations was USD 1.65 compared to USD 0.45 a year ago. Basic earnings per share was USD 1.47 compared to USD 0.21 a year ago. Diluted earnings per share was USD 1.44 compared to USD 0.21 a year ago.
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment develops, manufactures, and distributes rigid bracing products, orthopedic soft goods, vascular systems and compression garments, and hot and cold therapy products and offers recovery sciences products in the clinical rehabilitation and sports medicine markets, such as bone growth stimulators and electrical stimulators used for pain management. The Reconstructive segment develops, manufactures, and markets a variety of knee, hip, shoulder, elbow, foot, ankle, and finger implant products and surgical productivity tools. It also provides Novastep, a minimally invasive surgery (MIS) foot and ankle solutions.